Shawn Singh - May 12, 2022 Form 4 Insider Report for VistaGen Therapeutics, Inc. (VTGN)

Role
CHIEF EXECUTIVE OFFICER, Director
Signature
/s/ Jerrold D. Dotson, Attorney-in-Fact
Stock symbol
VTGN
Transactions as of
May 12, 2022
Transactions value $
$100,000
Form type
4
Date filed
5/16/2022, 01:39 PM
Previous filing
Mar 3, 2022
Next filing
Jul 15, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction VTGN Common Stock Options Exercise $100K +100K +204.09% $1.00* 149K May 12, 2022 Direct
holding VTGN Common Stock 26.2K May 12, 2022 By The 1997 Singh Family Trust U/R/D 05/29/97

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction VTGN Stock Option (Right to Buy) Options Exercise $0 -100K -58.82% $0.00 70K May 12, 2022 Common Stock 100K $1.00 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Stock option vested 25% on the grant date of September 5, 2019, with the remainder vesting monthly over the 36 months thereafter.